跳至主要内容
临床试验/CTRI/2021/01/030260
CTRI/2021/01/030260已完成2 期

RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF VAMANA FOLLOWED BY LASHUNA TAILAM MATRA BASTI IN POLYCYSTIC OVARIAN SYNDROME.

Dr Snehalata shivajirao pawar0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a)Female Patients between the reproductive age of 15-45 years
  • b)Both unmarried and married females.
  • c)Diagnosed cases of PCOS
  • d)Patients with Irregular cycles ( >35 or <21 days) continuing for more than 2 years after the onset of menarche
  • e)Patients with Irregular menses/scanty menses due to anovulatory cycle.
  • f)Patients with Signs and Symptoms of Artava Kshaya due to PCOS alone.
  • g)Patients fit for Vamana Karma and Matra Basti treatment.

排除标准

  • 1.Patients with abnormal menstrual cycle but not due to PCOS.
  • 2.Patients with Amenorrhea, Hirsutism and Obesity but not due to PCOS.
  • 3.Patients suffering from signs and symptoms of Artavakshaya Secondary to Hyper Thyroidisim, Tuberculosis, Anemia, Congenital Adrenal Hyperplasia, Androgen Secreting Tumors, Functional Hypothalamic Amenorrhea, Hyperprolactenaemia.
  • 4.Patients with Cervical Tumor, Polyp, Carcinoma Cervix, Uterine Fibroids, Tuberculous Endometritis.
  • 5.Patients with Cardiac Disorders, Congenital Anomalies of Reproductive Organs, Malignant Tumors of Reproductive Organs, Adrenal/Pituitary Tumors, Cushing Syndrome.
  • 6.Patients on Cytotoxic drugs
  • 7.Patients with HIV or Venereal diseases or Hepatitis B positive patients.
  • 8.Patients associated with any other severe systemic illness.
  • 9.Patient not fit for Vamana or Matra Basti Karmas.

研究者

发起方
Dr Snehalata shivajirao pawar

相似试验